Home › Degenerative Nerve Diseases › NCT07285954
Mindfulness Walking Intervention to Enhance Resilience (iWalk)
A Randomized Controlled Trial of a Walking Meditation Intervention (iWalk) to Enhance Resilience in Adults
Who can join
Ages 18 to 110 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. 18 years or older, 2. clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc., 3. have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs, 4. never received meditation training via coaching/certification/life coaching, 5. have internet access, 6. with no severe cognitive impairment, i.e., have a score of ≥ 21 on Modified Telephonic Interview for Cognitive Status (TICS-M), 7. be able to walk with or without an assistive device (Patient determined Disease Steps score ranged from 0-6), 8. are willing to be randomized to an intervention or a control group, 9. are willing to wear Fitbit (a wrist smart watch) for eight weeks, 10. are individuals who are right-handed according to the Edinburgh Handedness Questionnaire, 11. are willing to participate in all assessments, including in-person testing using electroencephalography (EEG) and cognitive tests, online survey/questionnaires, and online interviews or focus group discussions, 12. are willing to wear a Hexoskin t-shirt, which is a heart rate variability monitor, while doing the assessments in person. Exclusion Criteria: Participants who cannot speak, read, write, or listen in English.
About the study
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS).
The objectives are to evaluate:
1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.
What is being tested
- iWalk Program (behavioral)
Sponsor: University of Illinois at Urbana-Champaign · Participants: 90 · Started: Jun 1, 2025
Contact the study team
- Chung-Yi Chiu · Phone: 12172446435
Official record on ClinicalTrials.gov — NCT07285954
Locations in the U.S.
| Illinois | University of Illinois Urbana-Champaign, Urbana |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.